Company Shares of Qiagen N.V. (NASDAQ:QGEN) Rally 0.23%

On a relative basis, the stock has outperformed the S&P 500 by 0.41% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.23% in the last 1 week, and is up 2.03% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The company shares have dropped -15.55% from its 1 Year high price. On Sep 17, 2015, the shares registered one year high at $28.53 and the one year low was seen on Jun 27, 2016. The 50-Day Moving Average price is $21.56 and the 200 Day Moving Average price is recorded at $22.38.

The stock has recorded a 20-day Moving Average of 3.72% and the 50-Day Moving Average is 2.19%.


Qiagen N.V. (NASDAQ:QGEN): stock turned positive on Friday. Though the stock opened at $22.07, the bulls momentum made the stock top out at $22.17 level for the day. The stock recorded a low of $21.985 and closed the trading day at $22.15, in the green by 1.70%. The total traded volume for the day was 715,213. The stock had closed at $21.78 in the previous days trading.

QIAGEN N.V. (QIAGEN) is a Netherlands-based holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Sample to Insight molecular technologies are applicable across a range of applications and customer classes through more than 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. The Companys bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to interpret results and decide on further action.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.